First Time Loading...

Amryt Pharma Holdings Ltd
LSE:AMYT

Watchlist Manager
Amryt Pharma Holdings Ltd Logo
Amryt Pharma Holdings Ltd
LSE:AMYT
Watchlist
Price: 143 GBX -11.73% Market Closed
Updated: May 7, 2024

Amryt Pharma Holdings Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amryt Pharma Holdings Ltd
Cash from Financing Activities Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Amryt Pharma Holdings Ltd
LSE:AMYT
Cash from Financing Activities
$26m
CAGR 3-Years
-3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Cash from Financing Activities
-£6.4B
CAGR 3-Years
15%
CAGR 5-Years
-21%
CAGR 10-Years
1%
AstraZeneca PLC
LSE:AZN
Cash from Financing Activities
-$2.5B
CAGR 3-Years
1%
CAGR 5-Years
-4%
CAGR 10-Years
2%
Indivior PLC
LSE:INDV
Cash from Financing Activities
-$62m
CAGR 3-Years
-78%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Cash from Financing Activities
-$337m
CAGR 3-Years
-4%
CAGR 5-Years
-4%
CAGR 10-Years
-4%
Dechra Pharmaceuticals PLC
LSE:DPH
Cash from Financing Activities
£316.5m
CAGR 3-Years
39%
CAGR 5-Years
10%
CAGR 10-Years
N/A

See Also

What is Amryt Pharma Holdings Ltd's Cash from Financing Activities?
Cash from Financing Activities
26m USD

Based on the financial report for Dec 31, 2020, Amryt Pharma Holdings Ltd's Cash from Financing Activities amounts to 26m USD.

What is Amryt Pharma Holdings Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-3%

Over the last year, the Cash from Financing Activities growth was -61%. The average annual Cash from Financing Activities growth rates for Amryt Pharma Holdings Ltd have been -3% over the past three years .